Understanding how COVID-19 virus makes its RNA
Untangling the mechanisms of initiation and discontinuous RNA synthesis by COVID-19 RdRp
This study is looking at how the COVID-19 virus makes its genetic material, which could help scientists find new ways to fight the virus and improve treatments for people with COVID-19.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10629420 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms by which the SARS-CoV-2 virus synthesizes its RNA, focusing on the role of the RNA-dependent RNA polymerase (RdRp). The team will create a simplified laboratory model to study how the virus initiates and regulates RNA synthesis, using various biochemical techniques. By examining the interactions between viral proteins and RNA elements, the research aims to uncover critical factors that influence viral replication. This knowledge could lead to the development of new antiviral strategies to combat COVID-19.
Who could benefit from this research
Good fit: Patients who are at risk of severe COVID-19 or those who have been diagnosed with COVID-19 may benefit from this research.
Not a fit: Patients with non-viral respiratory infections or those not affected by COVID-19 are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective antiviral treatments for COVID-19.
How similar studies have performed: Previous research on viral RNA synthesis has shown promise in understanding other viruses, suggesting potential for success in this novel approach.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Weiss, Shimon — University of California Los Angeles
- Study coordinator: Weiss, Shimon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.